Scarica l'app Stockscreener
31.82
2.48%
0.77
Dopo l'orario di chiusura:
31.82
Avidity Biosciences Inc Borsa (RNA) Ultime notizie
Avidity Biosciences' CSTO Flanagan sells $416,153 in stock By Investing.com - Investing.com Australia
Avidity Biosciences CFO sells $364,191 in stock By Investing.com - Investing.com Australia
Avidity Biosciences CHRO Teresa McCarthy sells $364,191 in stock By Investing.com - Investing.com Australia
Avidity Biosciences Grants Major Stock Awards Package to Expand Team with 37 New Hires - StockTitan
Avidity Biosciences (NASDAQ:RNA) Shares Up 3.2%Time to Buy? - MarketBeat
Avidity Biosciences (NASDAQ:RNA) Coverage Initiated at HC Wainwright - MarketBeat
Avidity Biosciences shares initiated with Buy on establishment By Investing.com - Investing.com UK
What 8 Analyst Ratings Have To Say About Avidity Biosciences - Benzinga
Insider Selling: Avidity Biosciences, Inc. (NASDAQ:RNA) Insider Sells 12,742 Shares of Stock - MarketBeat
Avidity Biosciences, Inc. (NASDAQ:RNA) CEO Sells $1,040,384.30 in Stock - MarketBeat
Avidity Biosciences, Inc. (NASDAQ:RNA) CFO Michael F. Maclean Sells 11,151 Shares - MarketBeat
Avidity Biosciences' CSTO Flanagan sells $416,153 in stock - Investing.com
Avidity Biosciences CEO Sarah Boyce sells $1.04 million in stock - Investing.com
Avidity Biosciences CEO Sarah Boyce sells $1.04 million in stock By Investing.com - Investing.com UK
Insider Selling: Avidity Biosciences, Inc. (NASDAQ:RNA) Insider Sells 25,000 Shares of Stock - MarketBeat
Avidity Biosciences CHRO Teresa McCarthy sells $831,605 in stock By Investing.com - Investing.com South Africa
Avidity Biosciences CHRO Teresa McCarthy sells $831,605 in stock - Investing.com India
Geode Capital Management LLC Has $118.77 Million Stake in Avidity Biosciences, Inc. (NASDAQ:RNA) - MarketBeat
Avidity Biosciences (NASDAQ:RNA) Shares Gap DownHere's What Happened - MarketBeat
Avidity Biosciences, Inc. (NASDAQ:RNA) Shares Purchased by Barclays PLC - MarketBeat
Avidity Biosciences, Inc. (NASDAQ:RNA) Shares Purchased by Lord Abbett & CO. LLC - MarketBeat
Avidity Biosciences' SWOT analysis: RNA stock poised for growth in precision cardiology - Investing.com
Avidity Biosciences, Inc. (NASDAQ:RNA) Insider Sells $858,480.00 in Stock - MarketBeat
Avidity Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Eastern Progress Online
Avidity Biosciences' CSTO Flanagan sells $858,400 in stock By Investing.com - Investing.com UK
Avidity Biosciences Becomes Oversold (RNA) - Nasdaq
Avidity Biosciences to Participate in Upcoming Investor Conferen - GuruFocus.com
Avidity Biosciences to Participate in Upcoming Investor Conference - The Eastern Progress Online
State Street Corp Grows Stake in Avidity Biosciences, Inc. (NASDAQ:RNA) - MarketBeat
Neo Ivy Capital Management Acquires Shares of 16,596 Avidity Biosciences, Inc. (NASDAQ:RNA) - MarketBeat
Avidity Biosciences Announces Inducement Grants Under Nasdaq Lis - GuruFocus.com
Avidity Biosciences to Host Investor and Analyst Event Focused on Precision Cardiology Candidates and First Look at Next-Generation Technology Innovations on November 12, 2024 - Victoria Advocate
Avidity Biosciences Advances With FDA Clearance And Promising Data For Rare Diseases - Seeking Alpha
Avidity Biosciences Announces Pricing of Upsized Public Offering of Common Stock - The Eastern Progress Online
Wellington Management Group LLP Acquires 3,228,923 Shares of Avidity Biosciences, Inc. (NASDAQ:RNA) - MarketBeat
Castleark Management LLC Buys New Shares in Avidity Biosciences, Inc. (NASDAQ:RNA) - MarketBeat
Avidity Biosciences, Inc. (NASDAQ:RNA) Given Average Rating of "Buy" by Analysts - MarketBeat
Avidity Biosciences Announces FDA Removed Partial Clinical Hold on Delpacibart Etedesiran (del-desiran/AOC 1001) - The Eastern Progress Online
Avidity Biosciences Announces Proposed Public Offering of Common Stock - The Eastern Progress Online
Trend Tracker for (RNA) - Stock Traders Daily
Avidity Biosciences, Inc. (NASDAQ:RNA) Shares Acquired by RA Capital Management L.P. - MarketBeat
Avidity Biosciences, Inc. (NASDAQ:RNA) Shares Sold by RTW Investments LP - MarketBeat
Janus Henderson Group PLC Raises Stake in Avidity Biosciences, Inc. (NASDAQ:RNA) - MarketBeat
Cinctive Capital Management LP Sells 35,808 Shares of Avidity Biosciences, Inc. (NASDAQ:RNA) - MarketBeat
The Manufacturers Life Insurance Company Lowers Stake in Avidity Biosciences, Inc. (NASDAQ:RNA) - MarketBeat
Charles Schwab Investment Management Inc. Boosts Stock Position in Avidity Biosciences, Inc. (NASDAQ:RNA) - MarketBeat
2.88%
2.65%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):